Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Autolus Therapeutics Plc ADR (AUTL)

Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress GlobeNewswire - Wed May 14, 8:30AM CDT

AUTL : 1.3300 (+3.10%)
Autolus Therapeutics Reports First Quarter 2025 Financial Results and Business Updates GlobeNewswire - Thu May 8, 6:00AM CDT

AUTL : 1.3300 (+3.10%)
Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)(1) GlobeNewswire - Fri Apr 25, 11:06AM CDT

AUTL : 1.3300 (+3.10%)
Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event GlobeNewswire - Wed Apr 23, 3:05PM CDT

AUTL : 1.3300 (+3.10%)
Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 GlobeNewswire - Tue Apr 22, 6:00AM CDT

AUTL : 1.3300 (+3.10%)
Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference GlobeNewswire - Wed Apr 2, 6:00AM CDT

AUTL : 1.3300 (+3.10%)
Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025 GlobeNewswire - Tue Apr 1, 6:00AM CDT

AUTL : 1.3300 (+3.10%)
Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates GlobeNewswire - Thu Mar 20, 6:00AM CDT

AUTL : 1.3300 (+3.10%)
Autolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025 GlobeNewswire - Thu Mar 6, 6:00AM CST

AUTL : 1.3300 (+3.10%)
Autolus Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire - Wed Mar 5, 6:00AM CST

AUTL : 1.3300 (+3.10%)

Barchart Exclusives

3 Oversold Dividend Aristocrats Wall Street Says Are Ready to Rally Barchart - Fri May 16, 6:00PM CDT
Markets rise on improving geopolitical sentiment, leaving some quality dividend stocks to remain oversold. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot